Clinical Trial: EFFICACY AND TOLERABILITY OF TREATMENT WITH ALFALITIC PLUS SERENOA REPENS COMPARED TO ALFALITIC PLUS ANTIMUSCARINIC FOR MODERATE-SEVERE LOWER URINARY TRACT SYMPTOMS

U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07665749) titled 'EFFICACY AND TOLERABILITY OF TREATMENT WITH ALFALITIC PLUS SERENOA REPENS COMPARED TO ALFALITIC PLUS ANTIMUSCARINIC FOR MODERATE-SEVERE LOWER URINARY TRACT SYMPTOMS' on June 18.

Brief Summary: The study aims to investigate, through the International Prostatic Symptoms Score (IPSS) questionnaire, the non-inferiority of the therapy with the alpha-blockers+Serenoa repens combination compared to the alpha-blockers+antimuscarinic combination on storage lower urinary tract syndrome (LUTS) in patients with moderate-severe symptomatic benign prostatic hyperplasia (BPH).

Study Start Date: June 01

Study Type: OBSERVATIONAL

Condition: Beni...